Free Trial

Bausch Health Companies (BHC) Insider Trading & Ownership

Bausch Health Companies logo
$7.47 +0.08 (+1.08%)
(As of 12/20/2024 05:31 PM ET)

Bausch Health Companies (NYSE:BHC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.12%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$83,027.70
Get BHC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bausch Health Companies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BHC Insider Buying and Selling by Quarter

Bausch Health Companies Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/6/2024Seana CarsonEVPSell13,370$6.21$83,027.70  
(Data available from 1/1/2013 forward)

BHC Insider Trading Activity - Frequently Asked Questions

The list of insiders at Bausch Health Companies includes Joseph F Gordon, Robert Spurr, and Seana Carson. Learn more on insiders at BHC.

8.12% of Bausch Health Companies stock is owned by insiders. Learn more on BHC's insider holdings.

The following insider sold BHC shares in the last 24 months: Seana Carson ($143,051.77).

Insiders have sold a total of 20,610 Bausch Health Companies shares in the last 24 months for a total of $143,051.77 sold.

Bausch Health Companies Key Executives

  • Mr. Thomas J. Appio (Age 62)
    CEO & Director
    Compensation: $2.74M
  • Mr. John S. Barresi (Age 51)
    Senior VP, Controller, Chief Accounting Officer & Interim CFO
    Compensation: $796.8k
  • Ms. Seana CarsonMs. Seana Carson (Age 51)
    Executive VP & General Counsel
    Compensation: $872.65k
    1 recent trades
  • Mr. Mirza Dautbegovic
    Senior VP & COO
  • Mr. Josh Coyle
    Senior Vice President of Sales & Salix
  • Ms. Kathleen Fitzpatrick
    Senior VP & Chief HR Officer
  • Dr. Tage Ramakrishna M.D. (Age 50)
    Chief Medical Officer and President of R&D
  • Mr. Jeff Hartness
    Executive VP of Market Access, Commercial Operations, Neurology, Generics & Government Affairs
  • Dr. Graham Jackson
    Senior VP & Chief Quality Officer
  • Mr. Cees Heiman
    Senior Vice President of Europe & Canada


This page (NYSE:BHC) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners